Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The effects of oral sodium bicarbonate on extracellular water in patients with chronic renal failure
Source of recordUK Trials
ISRCTNISRCTN80601080
Date ISRCTN assigned23/01/2008
Local reference number(s)SOB06/version3.0
Public titleThe effects of oral sodium bicarbonate on extracellular water in patients with chronic renal failure
Scientific title
AcronymN/A
Disease/condition/study domainChronic kidney disease
Study hypothesisDoes oral sodium bicarbonate have an effect on extracellular water or blood pressure in patients with chronic kidney disease?
Design/methodologyRandomised double blind placebo controlled trial
Research ethics reviewEthics approval received from the Hull and East Riding Local Research Ethics Committee on the 21st August 2006 (ref: 06/Q1104/108).
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Chronic kidney disease (CKD) (creatinine greater than 180 mcmol/l or glomerular filtration rate [GFR] less than 60 ml/min)
2. Aged over 18 years, male and female
Participants - exclusion criteria1. Need for dialysis
2. Already taking oral sodium bicarbonate
3. Uncontrolled hypertension
4. Peripheral oedema
5. Nephrotic syndrome
6. Congestive cardiac failure
Patient information materialNot available in web format, please use the contact details below to request a patient information sheet.
Anticipated start date06/06/2007
Anticipated end date30/09/2008
Status of trialOngoing
Target number of participants60
InterventionsOral sodium bicarbonate 1.5 g three times a day for 4 weeks versus placebo. Follow up is complete at the end of the 4-week treatment period.
Primary outcome measure(s)Extracellular water and total body water measured by bromide space and deuterium dilution at 4 weeks.
Secondary outcome measure(s)The following will be assessed at 4 weeks:
1. Blood pressure
2. Bio-impedance measures of total body water (TBW) and extracellular fluid (ECF)
Sources of fundingBritish Renal Society (UK) (ref: 05-008)
Sponsor nameYork Hospitals NHS Trust (UK)
Sponsor detailsYork Hospital
Wigginton Road
York
United Kingdom
YO31 8HE
Sponsor emailcaroline.mozley@york.nhs.uk
Sponsor websitehttp://www.yorkhealthservices.org/
Contact nameDr Colin Jones
Contact detailsYork Hospital
Wigginton Road
York
United Kingdom
YO31 8HE
Contact emailcolin.h.jones@york.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN80601080
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central